HOB Biotech Group Corp Ltd (688656) — Cash Flow-to-Debt Ratio
HOB Biotech Group Corp Ltd (688656) has a Cash Flow-to-Debt Ratio of 0.25x as of September 2025, meaning its operating cash flow of CN¥34.39 Million could theoretically repay 0% of its total liabilities (CN¥136.22 Million) in one year. See HOB Biotech Group Corp Ltd free cash flow ratio to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
HOB Biotech Group Corp Ltd Cash Flow-to-Debt Ratio (2016–2024)
Historical debt coverage capacity for HOB Biotech Group Corp Ltd across 9 annual periods. Also explore 688656 shareholders equity momentum to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for HOB Biotech Group Corp Ltd (2016–2024)
Year-by-year debt coverage analysis for HOB Biotech Group Corp Ltd. For market capitalisation and broader financial context, see HOB Biotech Group Corp Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2024 | 0.46x | CN¥101.22 Million | CN¥220.67 Million | ▼ -38.1% |
| 2023 | 0.74x | CN¥102.69 Million | CN¥138.52 Million | ▲ +109.8% |
| 2022 | 0.35x | CN¥58.31 Million | CN¥164.99 Million | ▼ -68.3% |
| 2021 | 1.12x | CN¥104.79 Million | CN¥93.92 Million | ▲ +72.5% |
| 2020 | 0.65x | CN¥58.22 Million | CN¥90.02 Million | ▲ +25.9% |
| 2019 | 0.51x | CN¥68.57 Million | CN¥133.54 Million | ▲ +1.7% |
| 2018 | 0.50x | CN¥46.51 Million | CN¥92.10 Million | ▲ +47.9% |
| 2017 | 0.34x | CN¥22.26 Million | CN¥65.20 Million | ▲ +261.2% |
| 2016 | 0.09x | CN¥6.42 Million | CN¥67.94 Million | — |